Literature DB >> 29087957

A novel DAX-1 (NR0B1) mutation in a boy with X-linked adrenal hypoplasia congenita.

Karine Gerster1, Claudia Katschnig1, Sascha Wyss1, Anne Kolly1, Patrick Sproll1, Anna Biason-Lauber1, Daniel Konrad1.   

Abstract

BACKGROUND: X-linked adrenal hypoplasia congenita (AHC) is caused by mutations in DAX-1 (NR0B1) playing a key role in adrenal and reproductive development. CASE
PRESENTATION: Herein we report a 2.5-year-old boy who presented with acute adrenal failure. Family history revealed unexplained death in three brothers of the patient's mother during infancy. Molecular analysis of the DAX-1 gene revealed the presence of a novel hemizygous mutation, c.870C>A in exon 1, leading to the formation of a premature stop codon. The same mutation was identified in the patient's mother. The truncated mutant protein is most likely misfolded, sequestered in the endoplasmic reticulum and therefore cannot bind to and activate its target DNA sequences in the nucleus.
CONCLUSIONS: DAX-1 mutation must be considered when diagnosis of primary adrenocortical insufficiency is made, especially if there is a history of unexplained death of maternal male relatives.

Entities:  

Keywords:  DAX-1; X-linked adrenal hypoplasia congenital; adrenal insufficiency

Mesh:

Substances:

Year:  2017        PMID: 29087957     DOI: 10.1515/jpem-2017-0261

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  2 in total

1.  Isolated hypoaldosteronism as first sign of X-linked adrenal hypoplasia congenita caused by a novel mutation in NR0B1/DAX-1 gene: a case report.

Authors:  Lorenzo Iughetti; Laura Lucaccioni; Patrizia Bruzzi; Silvia Ciancia; Elena Bigi; Simona Filomena Madeo; Barbara Predieri; Florence Roucher-Boulez
Journal:  BMC Med Genet       Date:  2019-06-04       Impact factor: 2.103

2.  X-linked congenital adrenal hypoplasia: a case presentation.

Authors:  Hong Ouyang; Bo Chen; Na Wu; Ling Li; Runyu Du; Meichen Qian; Wenshu Yu; Yujing He; Xinyan Liu
Journal:  BMC Endocr Disord       Date:  2021-06-15       Impact factor: 2.763

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.